English

NANOBIOTIX S.A.

EDGAR

NBTX Report (type unavailable) · filed 2026-10-01

Annual consolidated revenue for 2025: about EUR 32.59M, using the latest reported figures. The previous period, 2024, was about EUR -7.191M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest fiscal year

Revenue

32.6 million EUR

2025 · EUR

Exact inputs and evidence

Revenue: 32593000 EUR Source

Operating margin

-33.19%

2025 · %

Exact inputs and evidence

Operating Income: -10818000 EUR Source
Revenue: 32593000 EUR Source

Operating cash flow

-33.4 million EUR

2025 · EUR

Exact inputs and evidence

Operating Cash Flow: -33422000 EUR Source

Free cash flow

-34 million EUR

2025 · EUR

Exact inputs and evidence

Operating Cash Flow: -33422000 EUR Source
Capital Expenditure: 538000 EUR Source

Cash and cash equivalents: 52.8 million EUR 2025-12-31 Source
Exact value

52750000 EUR
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-01.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 8 of 11 periods available· newest 2025-12-31
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 8 of 11 periods available· newest 2025-12-31
Total assets: 7 of 11 periods available· newest 2025-12-31
Total liabilities: 3 of 11 periods available· newest 2025-12-31
Current assets: 7 of 11 periods available· newest 2025-12-31
Current liabilities: 7 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+EUR 39.78 million

Prior period

−EUR 7.19 million

2024-01-01 – 2024-12-31
Current period

EUR 32.59 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

32593000 − -7191000 = 39784000 EUR

-7191000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
32593000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Year-over-year change in Revenue: 39784000 EUR Concept: fundies:Revenue Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 32593000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4172359 Filing: 000176085426000003 Input fundies:Revenue: -7191000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4173078 Filing: 000176085426000003
The citation records this snapshot. The page link may show a newer release later.
Net income
+EUR 44.17 million

Prior period

−EUR 68.13 million

2024-01-01 – 2024-12-31
Current period

−EUR 23.96 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-23961000 − -68132000 = 44171000 EUR

-68132000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-23961000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Year-over-year change in Net income: 44171000 EUR Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -23961000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4915444 Filing: 000176085426000003 Input fundies:NetIncome: -68132000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4916025 Filing: 000176085426000003
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−EUR 13.87 million

Prior period

−EUR 19.55 million

2024-01-01 – 2024-12-31
Current period

−EUR 33.42 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-33422000 − -19551000 = -13871000 EUR

-19551000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-33422000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Year-over-year change in Operating cash flow: -13871000 EUR Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -33422000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2684553 Filing: 000176085426000003 Input fundies:OperatingCashFlow: -19551000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2685124 Filing: 000176085426000003
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-36.4%

Prior period

EUR 846,000

2024-01-01 – 2024-12-31
Current period

EUR 538,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

538000 − 846000 = -308000 EUR

846000 EUR · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
538000 EUR · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Year-over-year change in Capital expenditure: -308000 EUR Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 538000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2689531 Filing: 000176085426000003 Input fundies:CapitalExpenditure: 846000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2690112 Filing: 000176085426000003
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

Revenue EUR 32.59 million 100% of revenue
Operating costs Derived EUR 43.41 million 133% of revenue
Operating income −EUR 10.82 million −33% of revenue
Tax, interest and other Derived EUR 13.14 million 40% of revenue
Net income −EUR 23.96 million −74% of revenue

Cash

Operating cash flow −EUR 33.42 million −103% of revenue
Capital expenditure EUR 538,000 1.7% of revenue
Free cash flow Derived −EUR 33.96 million −104% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2018 Operating loss: operating costs were 964% of revenue.
2019 Operating loss: operating costs were 1,941% of revenue.
2020 Operating loss: operating costs were 1,550% of revenue.
2021 Operating loss: operating costs were 2,086% of revenue.
2022 Operating loss: operating costs were 1,078% of revenue.
2023 Operating loss: operating costs were 174% of revenue.
2024 Not shown: operating income or net income is not reported.
2025 Operating loss: operating costs were 133% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2018 2018-01-01 – 2018-12-31	3479000	33546000 Derived	-30067000	278000 Derived	-30345000	-26401000 Derived	Source 2018-01-01 – 2018-12-31: 3479000 EUR Inspect Revenue Open source 2018-01-01 – 2018-12-31: -30067000 EUR Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -30345000 EUR Inspect Net Income Open source 2018-01-01 – 2018-12-31: -25985000 EUR Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 416000 EUR Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	2541000	49320000 Derived	-46779000	4136000 Derived	-50915000	-42260000 Derived	Source 2019-01-01 – 2019-12-31: 2541000 EUR Inspect Revenue Open source 2019-01-01 – 2019-12-31: -46779000 EUR Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -50915000 EUR Inspect Net Income Open source 2019-01-01 – 2019-12-31: -41169000 EUR Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 1091000 EUR Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	2512000	38940000 Derived	-36428000	-2838000 Derived	-33590000	-27634000 Derived	Source 2020-01-01 – 2020-12-31: 2512000 EUR Inspect Revenue Open source 2020-01-01 – 2020-12-31: -36428000 EUR Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -33590000 EUR Inspect Net Income Open source 2020-01-01 – 2020-12-31: -27538000 EUR Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 96000 EUR Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	2647000	55226000 Derived	-52579000	-5516000 Derived	-47063000	-30100000 Derived	Source 2021-01-01 – 2021-12-31: 2647000 EUR Inspect Revenue Open source 2021-01-01 – 2021-12-31: -52579000 EUR Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -47063000 EUR Inspect Net Income Open source 2021-01-01 – 2021-12-31: -29872000 EUR Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 228000 EUR Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	4776000	51478000 Derived	-46702000	10339000 Derived	-57041000	-37195000 Derived	Source 2022-01-01 – 2022-12-31: 4776000 EUR Inspect Revenue Open source 2022-01-01 – 2022-12-31: -46702000 EUR Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -57041000 EUR Inspect Net Income Open source 2022-01-01 – 2022-12-31: -37103000 EUR Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 92000 EUR Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	36207000	62986000 Derived	-26779000	12921000 Derived	-39700000	-12804000 Derived	Source 2023-01-01 – 2023-12-31: 36207000 EUR Inspect Revenue Open source 2023-01-01 – 2023-12-31: -26779000 EUR Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -39700000 EUR Inspect Net Income Open source 2023-01-01 – 2023-12-31: -12476000 EUR Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 328000 EUR Inspect Capital Expenditure Open source
2024 2024-01-01 – 2024-12-31	-7191000	61201000 Derived	-68392000	-260000 Derived	-68132000	-20397000 Derived	Source 2024-01-01 – 2024-12-31: -7191000 EUR Inspect Revenue Open source 2024-01-01 – 2024-12-31: -68392000 EUR Inspect Operating Income Open source 2024-01-01 – 2024-12-31: -68132000 EUR Inspect Net Income Open source 2024-01-01 – 2024-12-31: -19551000 EUR Inspect Operating Cash Flow Open source 2024-01-01 – 2024-12-31: 846000 EUR Inspect Capital Expenditure Open source
2025 2025-01-01 – 2025-12-31	32593000	43411000 Derived	-10818000	13143000 Derived	-23961000	-33960000 Derived	Source 2025-01-01 – 2025-12-31: 32593000 EUR Inspect Revenue Open source 2025-01-01 – 2025-12-31: -10818000 EUR Inspect Operating Income Open source 2025-01-01 – 2025-12-31: -23961000 EUR Inspect Net Income Open source 2025-01-01 – 2025-12-31: -33422000 EUR Inspect Operating Cash Flow Open source 2025-01-01 – 2025-12-31: 538000 EUR Inspect Capital Expenditure Open source

Amounts are exact, in EUR.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

EUR 32.6M 2025

Values and sources

Revenue values and source evidence
Period	Series	Value(EUR)	Source evidence
20182018-12-31	Revenue	3479000	Revenue: 3479000 Open source
20192019-12-31	Revenue	2541000	Revenue: 2541000 Open source
20202020-12-31	Revenue	2512000	Revenue: 2512000 Open source
20212021-12-31	Revenue	2647000	Revenue: 2647000 Open source
20222022-12-31	Revenue	4776000	Revenue: 4776000 Open source
20232023-12-31	Revenue	36207000	Revenue: 36207000 Open source
20242024-12-31	Revenue	-7191000	Revenue: -7191000 Open source
20252025-12-31	Revenue	32593000	Revenue: 32593000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-553.2% 2025

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Year over year	No prior comparable period	Revenue: 3479000 Open source
20192019-12-31	Year over year	-27%	Revenue: 2541000 Open source Revenue: 3479000 Open source
20202020-12-31	Year over year	-1.1%	Revenue: 2512000 Open source Revenue: 2541000 Open source
20212021-12-31	Year over year	5.4%	Revenue: 2647000 Open source Revenue: 2512000 Open source
20222022-12-31	Year over year	80.4%	Revenue: 4776000 Open source Revenue: 2647000 Open source
20232023-12-31	Year over year	658.1%	Revenue: 36207000 Open source Revenue: 4776000 Open source
20242024-12-31	Year over year	-119.9%	Revenue: -7191000 Open source Revenue: 36207000 Open source
20252025-12-31	Year over year	-553.2%	Revenue: 32593000 Open source Revenue: -7191000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -33.2% 2025

Net margin -73.5% 2025

Free cash flow margin -104.2% 2025

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20182018-12-31	Operating margin	-864.2%	Operating Income: -30067000 Open source Revenue: 3479000 Open source
20192019-12-31	Operating margin	-1,841%	Operating Income: -46779000 Open source Revenue: 2541000 Open source
20202020-12-31	Operating margin	-1,450.2%	Operating Income: -36428000 Open source Revenue: 2512000 Open source
20212021-12-31	Operating margin	-1,986.4%	Operating Income: -52579000 Open source Revenue: 2647000 Open source
20222022-12-31	Operating margin	-977.8%	Operating Income: -46702000 Open source Revenue: 4776000 Open source
20232023-12-31	Operating margin	-74%	Operating Income: -26779000 Open source Revenue: 36207000 Open source
20242024-12-31	Operating margin	951.1%	Operating Income: -68392000 Open source Revenue: -7191000 Open source
20252025-12-31	Operating margin	-33.2%	Operating Income: -10818000 Open source Revenue: 32593000 Open source
20182018-12-31	Net margin	-872.2%	Net Income: -30345000 Open source Revenue: 3479000 Open source
20192019-12-31	Net margin	-2,003.7%	Net Income: -50915000 Open source Revenue: 2541000 Open source
20202020-12-31	Net margin	-1,337.2%	Net Income: -33590000 Open source Revenue: 2512000 Open source
20212021-12-31	Net margin	-1,778%	Net Income: -47063000 Open source Revenue: 2647000 Open source
20222022-12-31	Net margin	-1,194.3%	Net Income: -57041000 Open source Revenue: 4776000 Open source
20232023-12-31	Net margin	-109.6%	Net Income: -39700000 Open source Revenue: 36207000 Open source
20242024-12-31	Net margin	947.5%	Net Income: -68132000 Open source Revenue: -7191000 Open source
20252025-12-31	Net margin	-73.5%	Net Income: -23961000 Open source Revenue: 32593000 Open source
20182018-12-31	Free cash flow margin	-758.9%	Revenue: 3479000 Open source Operating Cash Flow: -25985000 Open source Capital Expenditure: 416000 Open source
20192019-12-31	Free cash flow margin	-1,663.1%	Revenue: 2541000 Open source Operating Cash Flow: -41169000 Open source Capital Expenditure: 1091000 Open source
20202020-12-31	Free cash flow margin	-1,100.1%	Revenue: 2512000 Open source Operating Cash Flow: -27538000 Open source Capital Expenditure: 96000 Open source
20212021-12-31	Free cash flow margin	-1,137.1%	Revenue: 2647000 Open source Operating Cash Flow: -29872000 Open source Capital Expenditure: 228000 Open source
20222022-12-31	Free cash flow margin	-778.8%	Revenue: 4776000 Open source Operating Cash Flow: -37103000 Open source Capital Expenditure: 92000 Open source
20232023-12-31	Free cash flow margin	-35.4%	Revenue: 36207000 Open source Operating Cash Flow: -12476000 Open source Capital Expenditure: 328000 Open source
20242024-12-31	Free cash flow margin	283.6%	Revenue: -7191000 Open source Operating Cash Flow: -19551000 Open source Capital Expenditure: 846000 Open source
20252025-12-31	Free cash flow margin	-104.2%	Revenue: 32593000 Open source Operating Cash Flow: -33422000 Open source Capital Expenditure: 538000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

EUR -33.4M 2025

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(EUR)	Source evidence
20182018-12-31	Operating cash flow	-25985000	Operating Cash Flow: -25985000 Open source
20192019-12-31	Operating cash flow	-41169000	Operating Cash Flow: -41169000 Open source
20202020-12-31	Operating cash flow	-27538000	Operating Cash Flow: -27538000 Open source
20212021-12-31	Operating cash flow	-29872000	Operating Cash Flow: -29872000 Open source
20222022-12-31	Operating cash flow	-37103000	Operating Cash Flow: -37103000 Open source
20232023-12-31	Operating cash flow	-12476000	Operating Cash Flow: -12476000 Open source
20242024-12-31	Operating cash flow	-19551000	Operating Cash Flow: -19551000 Open source
20252025-12-31	Operating cash flow	-33422000	Operating Cash Flow: -33422000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

EUR -34M 2025

Values and sources

Free cash flow values and source evidence
Period	Series	Value(EUR)	Source evidence
20182018-12-31	Free cash flow	-26401000	Operating Cash Flow: -25985000 Open source Capital Expenditure: 416000 Open source
20192019-12-31	Free cash flow	-42260000	Operating Cash Flow: -41169000 Open source Capital Expenditure: 1091000 Open source
20202020-12-31	Free cash flow	-27634000	Operating Cash Flow: -27538000 Open source Capital Expenditure: 96000 Open source
20212021-12-31	Free cash flow	-30100000	Operating Cash Flow: -29872000 Open source Capital Expenditure: 228000 Open source
20222022-12-31	Free cash flow	-37195000	Operating Cash Flow: -37103000 Open source Capital Expenditure: 92000 Open source
20232023-12-31	Free cash flow	-12804000	Operating Cash Flow: -12476000 Open source Capital Expenditure: 328000 Open source
20242024-12-31	Free cash flow	-20397000	Operating Cash Flow: -19551000 Open source Capital Expenditure: 846000 Open source
20252025-12-31	Free cash flow	-33960000	Operating Cash Flow: -33422000 Open source Capital Expenditure: 538000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

224.7% 2025

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Liabilities / assets	Not reported	No source recorded
2019-12-31	Liabilities / assets	Not reported	Total Assets: 56205000 Open source
2020-12-31	Liabilities / assets	Not reported	Total Assets: 134030000 Open source
2021-12-31	Liabilities / assets	Not reported	Total Assets: 101769000 Open source
2022-12-31	Liabilities / assets	Not reported	Total Assets: 59769000 Open source
20232023-12-31	Liabilities / assets	102%	Total Liabilities: 95739000 Open source Total Assets: 93897000 Open source
20242024-12-31	Liabilities / assets	197.5%	Total Liabilities: 133122000 Open source Total Assets: 67418000 Open source
20252025-12-31	Liabilities / assets	224.7%	Total Liabilities: 152242000 Open source Total Assets: 67760000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.09× 2025

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2018-12-31	Current assets / current liabilities	Not reported	No source recorded
20192019-12-31	Current assets / current liabilities	3.22×	Current Assets: 46127000 Open source Current Liabilities: 14347000 Open source
20202020-12-31	Current assets / current liabilities	6.58×	Current Assets: 125248000 Open source Current Liabilities: 19041000 Open source
20212021-12-31	Current assets / current liabilities	2.53×	Current Assets: 93060000 Open source Current Liabilities: 36845000 Open source
20222022-12-31	Current assets / current liabilities	1.38×	Current Assets: 52358000 Open source Current Liabilities: 37936000 Open source
20232023-12-31	Current assets / current liabilities	1.75×	Current Assets: 87339000 Open source Current Liabilities: 49873000 Open source
20242024-12-31	Current assets / current liabilities	1.04×	Current Assets: 61466000 Open source Current Liabilities: 58935000 Open source
20252025-12-31	Current assets / current liabilities	1.09×	Current Assets: 62750000 Open source Current Liabilities: 57507000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−EUR 30.35 million Exact value Exact value: -30345000 EUR 2018-01-01 – 2018-12-31: -30345000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2018-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -30345000 EUR Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -30345000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm#5812784 Filing: 000162828021006685 The citation records this snapshot. The page link may show a newer release later.	−EUR 25.99 million Exact value Exact value: -25985000 EUR 2018-01-01 – 2018-12-31: -25985000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2018-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -25985000 EUR Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -25985000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm#2733031 Filing: 000162828021006685 The citation records this snapshot. The page link may show a newer release later.	EUR 416,000 Exact value Exact value: 416000 EUR 2018-01-01 – 2018-12-31: 416000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2018-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 416000 EUR Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 416000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm#2740668 Filing: 000162828021006685 The citation records this snapshot. The page link may show a newer release later.	−EUR 26.4 million Calculation and evidence -25985000 − 416000 EUR Exact free cash flow: -26401000 EUR 2018-01-01 – 2018-12-31: -25985000 EUR · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 416000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2018-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -26401000 EUR Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -25985000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm#2733031 Filing: 000162828021006685 Input fundies:CapitalExpenditure: 416000 EUR (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm#2740668 Filing: 000162828021006685 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−EUR 50.92 million Exact value Exact value: -50915000 EUR 2019-01-01 – 2019-12-31: -50915000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2019-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -50915000 EUR Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -50915000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm#5981642 Filing: 000162828022008842 The citation records this snapshot. The page link may show a newer release later.	−EUR 41.17 million Exact value Exact value: -41169000 EUR 2019-01-01 – 2019-12-31: -41169000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2019-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -41169000 EUR Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -41169000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm#2774437 Filing: 000162828022008842 The citation records this snapshot. The page link may show a newer release later.	EUR 1.09 million Exact value Exact value: 1091000 EUR 2019-01-01 – 2019-12-31: 1091000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2019-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 1091000 EUR Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 1091000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm#2781689 Filing: 000162828022008842 The citation records this snapshot. The page link may show a newer release later.	−EUR 42.26 million Calculation and evidence -41169000 − 1091000 EUR Exact free cash flow: -42260000 EUR 2019-01-01 – 2019-12-31: -41169000 EUR · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 1091000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2019-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -42260000 EUR Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -41169000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm#2774437 Filing: 000162828022008842 Input fundies:CapitalExpenditure: 1091000 EUR (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000162828022008842/nbx-20211231.htm#2781689 Filing: 000162828022008842 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−EUR 33.59 million Exact value Exact value: -33590000 EUR 2020-01-01 – 2020-12-31: -33590000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2020-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -33590000 EUR Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -33590000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085423000005/nbx-20221231.htm#6349482 Filing: 000176085423000005 The citation records this snapshot. The page link may show a newer release later.	−EUR 27.54 million Exact value Exact value: -27538000 EUR 2020-01-01 – 2020-12-31: -27538000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2020-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -27538000 EUR Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -27538000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085423000005/nbx-20221231.htm#2954669 Filing: 000176085423000005 The citation records this snapshot. The page link may show a newer release later.	EUR 96,000 Exact value Exact value: 96000 EUR 2020-01-01 – 2020-12-31: 96000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2020-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 96000 EUR Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 96000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085423000005/nbx-20221231.htm#2961921 Filing: 000176085423000005 The citation records this snapshot. The page link may show a newer release later.	−EUR 27.63 million Calculation and evidence -27538000 − 96000 EUR Exact free cash flow: -27634000 EUR 2020-01-01 – 2020-12-31: -27538000 EUR · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 96000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2020-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -27634000 EUR Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -27538000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085423000005/nbx-20221231.htm#2954669 Filing: 000176085423000005 Input fundies:CapitalExpenditure: 96000 EUR (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085423000005/nbx-20221231.htm#2961921 Filing: 000176085423000005 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−EUR 47.06 million Exact value Exact value: -47063000 EUR 2021-01-01 – 2021-12-31: -47063000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2021-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -47063000 EUR Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -47063000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085424000004/nbx-20231231.htm#5276569 Filing: 000176085424000004 The citation records this snapshot. The page link may show a newer release later.	−EUR 29.87 million Exact value Exact value: -29872000 EUR 2021-01-01 – 2021-12-31: -29872000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2021-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -29872000 EUR Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -29872000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085424000004/nbx-20231231.htm#2867360 Filing: 000176085424000004 The citation records this snapshot. The page link may show a newer release later.	EUR 228,000 Exact value Exact value: 228000 EUR 2021-01-01 – 2021-12-31: 228000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2021-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 228000 EUR Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 228000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085424000004/nbx-20231231.htm#2872657 Filing: 000176085424000004 The citation records this snapshot. The page link may show a newer release later.	−EUR 30.1 million Calculation and evidence -29872000 − 228000 EUR Exact free cash flow: -30100000 EUR 2021-01-01 – 2021-12-31: -29872000 EUR · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 228000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2021-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -30100000 EUR Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -29872000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085424000004/nbx-20231231.htm#2867360 Filing: 000176085424000004 Input fundies:CapitalExpenditure: 228000 EUR (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085424000004/nbx-20231231.htm#2872657 Filing: 000176085424000004 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−EUR 57.04 million Exact value Exact value: -57041000 EUR 2022-01-01 – 2022-12-31: -57041000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2022-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -57041000 EUR Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -57041000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm#5154717 Filing: 000176085425000005 The citation records this snapshot. The page link may show a newer release later.	−EUR 37.1 million Exact value Exact value: -37103000 EUR 2022-01-01 – 2022-12-31: -37103000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2022-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -37103000 EUR Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -37103000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm#2888544 Filing: 000176085425000005 The citation records this snapshot. The page link may show a newer release later.	EUR 92,000 Exact value Exact value: 92000 EUR 2022-01-01 – 2022-12-31: 92000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2022-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 92000 EUR Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 92000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm#2893542 Filing: 000176085425000005 The citation records this snapshot. The page link may show a newer release later.	−EUR 37.2 million Calculation and evidence -37103000 − 92000 EUR Exact free cash flow: -37195000 EUR 2022-01-01 – 2022-12-31: -37103000 EUR · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 92000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2022-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -37195000 EUR Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37103000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm#2888544 Filing: 000176085425000005 Input fundies:CapitalExpenditure: 92000 EUR (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085425000005/nbx-20241231.htm#2893542 Filing: 000176085425000005 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−EUR 39.7 million Exact value Exact value: -39700000 EUR 2023-01-01 – 2023-12-31: -39700000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2023-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -39700000 EUR Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -39700000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4916606 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	−EUR 12.48 million Exact value Exact value: -12476000 EUR 2023-01-01 – 2023-12-31: -12476000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2023-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -12476000 EUR Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -12476000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2685695 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	EUR 328,000 Exact value Exact value: 328000 EUR 2023-01-01 – 2023-12-31: 328000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2023-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 328000 EUR Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 328000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2690693 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	−EUR 12.8 million Calculation and evidence -12476000 − 328000 EUR Exact free cash flow: -12804000 EUR 2023-01-01 – 2023-12-31: -12476000 EUR · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 328000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2023-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -12804000 EUR Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12476000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2685695 Filing: 000176085426000003 Input fundies:CapitalExpenditure: 328000 EUR (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2690693 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−EUR 68.13 million Exact value Exact value: -68132000 EUR 2024-01-01 – 2024-12-31: -68132000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2024-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -68132000 EUR Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -68132000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4916025 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	−EUR 19.55 million Exact value Exact value: -19551000 EUR 2024-01-01 – 2024-12-31: -19551000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2024-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -19551000 EUR Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -19551000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2685124 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	EUR 846,000 Exact value Exact value: 846000 EUR 2024-01-01 – 2024-12-31: 846000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2024-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 846000 EUR Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 846000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2690112 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	−EUR 20.4 million Calculation and evidence -19551000 − 846000 EUR Exact free cash flow: -20397000 EUR 2024-01-01 – 2024-12-31: -19551000 EUR · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 846000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2024-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -20397000 EUR Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19551000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2685124 Filing: 000176085426000003 Input fundies:CapitalExpenditure: 846000 EUR (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2690112 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−EUR 23.96 million Exact value Exact value: -23961000 EUR 2025-01-01 – 2025-12-31: -23961000 EUR Inspect Net Income Open source Share or cite Citation for Net Income · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Net Income: -23961000 EUR Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=EUR&dimensions= Input fundies:NetIncome: -23961000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#4915444 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	−EUR 33.42 million Exact value Exact value: -33422000 EUR 2025-01-01 – 2025-12-31: -33422000 EUR Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Operating Cash Flow: -33422000 EUR Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=EUR&dimensions= Input fundies:OperatingCashFlow: -33422000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2684553 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	EUR 538,000 Exact value Exact value: 538000 EUR 2025-01-01 – 2025-12-31: 538000 EUR Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Capital Expenditure: 538000 EUR Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=EUR&dimensions= Input fundies:CapitalExpenditure: 538000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2689531 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.	−EUR 33.96 million Calculation and evidence -33422000 − 538000 EUR Exact free cash flow: -33960000 EUR 2025-01-01 – 2025-12-31: -33422000 EUR · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 538000 EUR · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NANOBIOTIX S.A. · 2025-12-31 NANOBIOTIX S.A. (edgar:1760854) Free cash flow: -33960000 EUR Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T07:44:23Z Snapshot: c289f3b87abe87daa61ed44fc06af12b3c2a3e4b6cc7174e1f8de84e8c8390f6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1760854?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -33422000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2684553 Filing: 000176085426000003 Input fundies:CapitalExpenditure: 538000 EUR (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1760854/000176085426000003/nbx-20251231.htm#2689531 Filing: 000176085426000003 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

240 filings · 807 latest values · 807 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001760854, 1760854, NBTX, edgar:1760854

Also known as NANOBIOTIX S.A., Nanobiotix S.A.

NANOBIOTIX S.A.

Latest fiscal year

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2025 2025-01-01 – 2025-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation